Showing results (631-640 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|November 27, 2010
Cost of illness in patients with metastatic colorectal cancerXue Song, Zhongyun Zhao, Beth Barber, et al.Journal of Medical Economics|January 18, 2011
The economic burden of advanced Parkinson’s disease: an analysis of a UK patient datasetLeslie J Findley, Eifiona Wood, Julia Lowin, et al.Journal of Medical Economics|January 4, 2011
The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspectiveR F Pollock, W J Valentine, T Pilgaard, et al.Journal of Medical Economics|July 29, 2010
Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohortsJane Castelli-Haley, Merrikay A Oleen-Burkey, Maureen J Lage, et al.Journal of Medical Economics|March 10, 2011
An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacementCorinne Lereun, Phillip Wells, Alex Diamantopoulos, et al.Journal of Medical Economics|April 5, 2011
Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic reviewDonna R Parker, Xuemei Luo, Jessica J Jalbert, et al.Journal of Medical Economics|March 24, 2021
Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists?Stephen P McKenna, Alice HeaneyJournal of Medical Economics|March 25, 2021
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in GermanyRui Cai, Laetitia Gerlier, Martin Eichner, et al.Journal of Medical Economics|July 18, 2019
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UKStephen C Bain, Brian Bekker Hansen, Barnaby Hunt, et al.Journal of Medical Economics|April 19, 2024
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims dataGünter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, et al.Pageof 241